The Evolution and Challenges of the Nicotine Pouch Market: From Niche Product to Mainstream Controversy
The nicotine pouch market has seen quite a change since I started using pouches myself back in 2020. At that time, you might get lucky and find a display pack that had found its way into a convenience store so you could buy the product in person. However, an initially fledgling online marketplace rapidly grew to meet consumer demand. We’re now (finally) starting to see nicotine pouches not only sold online but also in high street stores and supermarkets. Nicotine pouches, whilst still not as visible as I might like, are far more known by the general public, and newspapers have certainly got wind of the rising trend!
Contents
ZYN the News
Not all of this newfound attention is positive. Typical scare stories around youth usage, has-been footballers declaring them the devil, and stranger still, ‘ZYN’ nicotine pouches appear to have found themselves thrust into the United States’ increasingly confusing cultural and political conflicts. My colleague Joseph has written a range of pieces on the topic, from job creation to the type of coverage that can be seen in The Economist or Bloomberg News.
Bloomberg News recently reported on a ZYN shortage in the US market, highlighting how this gap has led to new companies rushing to fill the demand. However, their article raises questions about the actual size of the nicotine pouch market. According to consumer intelligence firm NIQ, retail sales of oral nicotine pouches amount to just $6 million of a nearly $80 billion market—a mere 0.0076%.
The Wall Street Journal took a more balanced approach, explaining the potential of nicotine pouches to help smokers quit. They quoted the FDA stating that nicotine itself does not cause cancer, providing a factual basis often missing in discussions about nicotine products.
As with all products that reach a certain popularity, in some parts of the world, we are starting to see counterfeit products now too. A quick browse on the r/NicotinePouch subreddit and you’ll quickly come across posts like this—people questioning the legitimacy of their purchases—an issue that seems to (so far) mainly affect ZYN products in the US and Canada.
Cheap Imitations
So, as with all products, it’s reached the point in its lifecycle where the Chinese have started to copy it. It might be flattering if it didn’t raise serious concerns around product quality and safety. Nicotine pouch legislation across the globe is generally either non-existent or simply bans the product outright. Here where I am in the United Kingdom, at the time of writing, there are no laws around the age of sale, ingredient quality, strength, or packaging whatsoever. I’ve written to the (previous) government about these issues before and will be following up with a new letter to the current government soon.
The current wild west marketplace, especially online, but slowly finding its way onto the high streets, is of course going to lead to low-quality or counterfeit products when there’s essentially no legislation besides brand trademarking to stop them. Even when we look at ‘legitimate’ online stores, especially in the UK, you’ll quickly come across extremely strong (40-50mg+ per pouch) nicotine products with an entirely unknown supply chain and no guarantees when it comes to quality or safety. Big Tobacco does a great job at their due diligence, their online stores enforcing age checks and products typically sold ‘behind the counter’ in chain stores. However, every week a new brand pops up online or in your local vape shop.
Growth and the Important of Sensible Legislation
On one hand, it’s great to see a visible rise in the prominence of nicotine pouches, but increased exposure was always going to come with increased scrutiny. This is why I’ve always advocated for sensible legislation to ensure they remain a safe and less harmful alternative for smokers looking to move away from combustible cigarettes.
The nicotine pouch market has seen significant growth, particularly with brands like ZYN. According to The Wall Street Journal, ZYN’s sales increased by around 80% in the last year. This growth has attracted both positive attention from investors and scrutiny from regulators and politicians.
However, this rapid growth has not been without challenges. In the US, the FDA’s slow pace in approving nicotine pouches has created opportunities for less regulated alternatives to enter the market. As Bloomberg News reported, there’s concern about “a flurry of new pouch brands,” many of which are Chinese-made, potentially bypassing regulatory standards.
Political and Cultural Implications
Interestingly, nicotine pouches have found themselves at the centre of cultural and political debates. Some politicians, like Senator Chuck Schumer, have called for federal regulators to investigate these products, claiming they target young people. However, these claims often lack substantial evidence and misunderstand the nature of social media trends around the product.
The politicisation of nicotine pouches risks overshadowing the public health discussion. As we’ve previously noted, “Nicotine pouches aren’t about Trump, or ‘wokeism’, or the ethnicity of the lead in big-budget movies. They’re about public health, which affects everyone.”
Looking Forward
As the nicotine pouch market continues to evolve, it faces several challenges. These include navigating complex regulatory landscapes, addressing misconceptions about nicotine, and balancing market growth with responsible marketing practices. The industry’s ability to address these challenges will likely shape its future trajectory and public perception.
Read more
